Transcatheter Interventions Online 2024 - On Demand
Published: 20 March 2024
-
Views:
4199
-
Likes:
7
-
Views:
4199
-
Likes:
7
-
Up Next -
59m 46sPart 3 | Session 4 Session 3.3: Controversies -
4m 16sPart 3 | Session 5 Day Three Close
-
3m 36sPart 1 | Session 1 Day Welcome: Structural Heart Disease Nicolas M Van Mieghem, Kendra J Grubb, Roxana Mehran, Ajay J Kirtane, David Hildick-Smith, Holger Thiele
-
59m 1sPart 1 | Session 2 Session 1.1: New Perspectives on Transcatheter Atrioventricular Valve Interventions Nicolas M Van Mieghem, Ole De Backer, Kendra J Grubb, Azeem Latib, Didier Tchétché
-
59m 33sPart 1 | Session 3 Session 1.2 Live Cases & Discussions Nicolas M Van Mieghem, Ole De Backer, Kendra J Grubb, Azeem Latib
-
39m 31sPart 1 | Session 4 Session 1.3: Revalving for Transcatheter Heart Valve Failure Kendra J Grubb, Nicolas M Van Mieghem, Giuseppe Tarantini, Holger Thiele, David Hildick-Smith
-
50m 48sPart 1 | Session 5 Session 1.4: Live Cases & Discussions Kendra J Grubb, Giuseppe Tarantini, Holger Thiele, David Hildick-Smith
-
1m 46sPart 1 | Session 6 Day One Close Kendra J Grubb
-
3m 9sPart 2 | Session 1 Day Welcome: Complex PCI Ajay J Kirtane
-
51m 36sPart 2 | Session 2 Session 2.1: Coronary Calcifications Updates Ajay J Kirtane, Margaret McEntegart, Azeem Latib, Giuseppe Tarantini, Holger Thiele
-
1h 5m 33sPart 2 | Session 3 Session 2.2: Live Cases & Discussions Ajay J Kirtane, Margaret McEntegart, Azeem Latib, Giuseppe Tarantini
-
58m 49sPart 2 | Session 4 Session 2.3: Imaging Focus Roxana Mehran, Joost Daemen, David Hildick-Smith, Ajay J Kirtane, Natalia Pinilla
-
1h 5m 56sPart 2 | Session 5 Session 2.4: Live Cases & Discussions Roxana Mehran, Joost Daemen, David Hildick-Smith, Ajay J Kirtane, Natalia Pinilla
-
3m 57sPart 2 | Session 6 Day Two Close Roxana Mehran
-
2mPart 3 | Session 1 Day Welcome: Debates & Controversies Nicolas M Van Mieghem
-
1h 1m 13sPart 3 | Session 2 Session 3.1: Keynote & Debates Nicolas M Van Mieghem, Michael J Mack, Kendra J Grubb, Giuseppe Tarantini
Overview
TIO 2024 brought together an outstanding international faculty, creating an unparalleled interactive experience that will keep the global interventional cardiology community up-to-date with the latest advancements in transcatheter treatment strategies. Featuring a combination of expert opinions, engaging discussions, insightful presentations and live cases from prominent medical centres on both sides of the Atlantic, TIO delivered the highest-quality CME-accredited education.
Related Content:
Key Learning Objectives
- Review planning and valve selection strategies in patients with prior valve failure
- Summarise recent repair and replacement data in mitral and tricuspid regurgitation
- Select suitable tools for undertaking PCI in calcified lesions
- Optimise use of imaging in daily practice
- Outline the pros and cons of using P2Y12 inhibitors universally following PCI
- Identify situations where an IVUS or OCT-guided approach are preferable
- Discuss the possible implications of TAVR becoming a care option in asymptomatic aortic stenosis
Target Audience
- Interventional Cardiologists
- Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
- Interventional Cardiology Nurses
More from this programme
Part 1
Day One: Structural Heart Disease
Part 2
Day Two: Complex PCI
Part 3
Day Three: Debates & Controversies
Faculty Biographies
Nicolas M Van Mieghem
Medical Director
Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.
Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors.
His current research focuses on cerebral embolic protection during TAVI and the search for improved…
Kendra J Grubb
Surgical Director
Dr Kendra Grubb is the surgical director of the Emory Structural Heart and Valve Center. She is also an associate professor of surgery at Emory University School of Medicine.
Kendra is a champion for women's heart disease and is dedicated to improving the lives of all patients through innovation, collaboration and a patient-centred approach to the treatment of cardiovascular disease.
Her clinical interests include valve repair or replacement, coronary artery bypass graft surgery (CABG), transcatheter aortic valve replacement (TAVR) and hybrid coronary revascularization.
Dr Grubb research interests are innovative cardiac surgery technologies. She has led and participated in multiple clinical trials of innovative cardiac surgery technologies, including studies of transcatheter aortic valve replacement (TAVR), MitraClip percutaneous therapy and the GORE® conformable TAG® thoracic endoprosthesis for the primary treatment of…
Giuseppe Tarantini
Prof Giuseppe Tarantini is the Head of the Interventional Cardiology Unit within the Department of Cardiac, Thoracic, and Vascular Sciences at the University of Padua Medical School, Padua, IT. He is a globally recognised researcher specialising in ischemic heart disease, structural heart disease, and cardiomyopathies.
Prof Tarantini serves as the primary operator for a diverse array of interventional procedures, encompassing coronary interventions (including atherectomies), peripheral interventions (such as carotid and renal procedures), and structural heart interventions (involving ASDs, PFOs, TAVI, and AVP).
In addition to his clinical work, Prof Tarantini is a distinguished faculty member at various international conferences, including Transcatheter Cardiovascular Therapeutics (TCT), the Congresso della Societa Italiana di Cardiologia Invasiva (SICI-GISE), Euro PCR, and the European Society of Cardiology (ESC). He boasts a publication record of 245 clinical…
Ole De Backer
Interventional Cardiologist
Prof Ole De Backer is an internationally renowned interventional cardiologist working at Rigshospitalet, Copenhagen University Hospital, Denmark and is an expert in structural heart interventions – among others transcatheter heart valve interventions, percutaneous left atrial appendage closure and thoracic endovascular aortic repair. Special areas of interest are the development and adoption of a fully percutaneous, minimal invasive approach for different structural heart interventions and the use of advanced cardiac imaging tools for planning and guidance of these interventions. He is actively involved and leading several research projects in the field of transcatheter heart valves and percutaneous left atrial appendage closure.
Joost Daemen
Interventional Cardiologist
Dr Joost Daemen, MD, PhD is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam.
Dr Daemen is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.
Comments